-transparent.png){kind=logo}
Dopamine (DA) elevations in rat striatum produced by combined administration of L-dopa and carbidopa were abolished when L-dopa was injected with NSD-1015, an inhibitor of central dopa-decarboxylase. In all rats with unilateral 6-OH-DA nigral lesions, L-dopa-induced contraversive circling occurred after carbidopa, but was totally abolished (in 60%) or markedly suppressed after pretreatment with NSD-1015. Administration of the DA metabolites DOPAC and HVA systemically and of 3-methoxytyramine intrastriatally evoked no circling in animals with 6-OH-DA lesions. In rats with unilateral nigrotomies, the direction of L-dopa-induced circling was reversed and became ipsiversive after DA receptors were reduced by the addition of kainic acid lesions in ipsilateral striata. Findings provide evidence that circling in rats--and by analogy, efficacy in parkinsonians--requires the decarboxylation of exogenous L-dopa and interaction of the formed DA with DA receptors in striatum.
E Melamed, and
F Hefti, and
V Bitton, and
M Globus
July 1981,
Pharmacology, biochemistry, and behavior,
E Melamed, and
F Hefti, and
V Bitton, and
M Globus
January 1971,
Psychiatria, neurologia, neurochirurgia,
E Melamed, and
F Hefti, and
V Bitton, and
M Globus
January 2001,
The European journal of neuroscience,
E Melamed, and
F Hefti, and
V Bitton, and
M Globus
March 2008,
Basic & clinical pharmacology & toxicology,
E Melamed, and
F Hefti, and
V Bitton, and
M Globus
July 1972,
Neurology,
E Melamed, and
F Hefti, and
V Bitton, and
M Globus
November 1970,
Biochemical medicine,
E Melamed, and
F Hefti, and
V Bitton, and
M Globus
July 1976,
European journal of pharmacology,
E Melamed, and
F Hefti, and
V Bitton, and
M Globus
March 1974,
Nihon rinsho. Japanese journal of clinical medicine,
E Melamed, and
F Hefti, and
V Bitton, and
M Globus
February 1975,
La Clinica terapeutica,
E Melamed, and
F Hefti, and
V Bitton, and
M Globus
June 1976,
European journal of pharmacology,
